Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...

Clopidogrel (Clopicard 75mg) is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. Clopidogrel (Clopicard 75mg) is prescribed ...

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Clopidogrel Tablets USP 75mg, which is being launched. Clopidogrel Tablets USP ...

Plavix Clopidogrel buy plavix 75 mg advisable to prevent blood clots after a recent heart attack or allergy. It is also important by patients with certain disorders of the incidence or blood vessels.

September 18, 2006 — Health Canada has approved inhaled ciclesonide for the prophylaxis of steroid-responsive bronchial asthma in patients aged 18 years or older; the European Commission has approved ...

After planned clopidogrel cessation, platelet reactivity soon returns to baseline levels, showing no evidence of a rebound effect in patients with stable coronary artery disease (CAD) or peripheral ...

International Laboratories, LLC is notifying distributors and customers by letter and is arranging for return of all recalled products. International Laboratories announced a voluntary recall of 1 lot ...

Golden State Medical Supply, Inc. has voluntarily recalled 1 lot of Clopidogrel 75mg Tablets and 1 lot of Atenolol 25mg Tablets due to a report stating that a bottle containing Clopidogrel 75mg ...

Diminished antiplatelet effect in patients with two loss-of-function alleles of the CYP2C19 gene. Increased risk of bleeding. Premature discontinuation increases risk of cardiovascular events; if ...